ArticleOncoTargets and therapy2021

PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.

Manavi Sachdeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.